study was carried out over three periods on 25 beds of the anesthesia and reanimation ICU (ARICU) and 9 beds of the neurology ICU (NICU), between May 2011 and December 2015. All patients in these ICUs were followed daily by infectious disease and clinical microbiology specialists (IDCMS). In each period, similar infection control measures were performed. All data were obtained from patient files retrospectively.
Infection-related mortality for each period was calculated as patients who died after hospital infection diagnosis divided by number of patients hospitalized in the ICU during the same period.
2.2. Antibiotic prescription Antibiotics were divided into two groups due to reimbursement restrictions in Turkey: restricted antibiotics (reimbursed when prescribed only by infectious disease specialists) and unrestricted antibiotics (reimbursed when prescribed by any doctor). Restricted antibiotics were imipenem, meropenem, doripenem, ertapenem, vancomycin, teicoplanin, daptomycin, linezolid, colistin, piperacillin/tazobactam, sulbactam, cefepime, cefoperazone/sulbactam, intravenous quinolones, and tigecycline.
Sakarya University Education and Training Hospital has a hospital information management system. Antibiotics were prescribed only by IDCMS, according to legal regulations in Turkey.
Study periods
The study was conducted in three periods. All patients were examined in the ICU before antibiotic prescription during all periods.
Study period 1 (SP-1): May 2011-February 2012
During this period, G2C was prescribed by IDCMS working in the hospital without restriction.
Study period 2 (SP-2): May 2012-September 2013
The use of G2C in SP-2 was restricted either in empirical use or after obtaining antibiogram results. According to the antibiogram results, G2C was not used if there was a chance of using other antibiotics other than G2C. Ertapenem, a carbapenem outside G2C, was prescribed freely.
Study period 3 (SP-3): October 2013-December 2015
During this period, G2C restriction was removed and IDCMS represcribed all carbapenems without any restriction for patients in need. In other words, antibiotic prescription rules returned to the rules in SP-1.
Antibiotic consumption data
The consumption of all antibiotics was obtained on a box basis from the data on the hospital information management system. According to the definition of daily defined dose (DDD) reported by the World Health Organization, antibiotics are transformed into value of DDD (12).
Inclusion criteria
All patients who were treated in ARICU and NICU in our hospital were included in the study. Infection and colonization were determined according to the Centers for Disease Control (CDC) hospital infection diagnostic criteria as defined elsewhere (13).
Exclusion criteria
Patients who were under 18 years old were excluded from the study.
Infection control procedures
Infection control procedures include avoiding use of unnecessary invasive applications, compliance to aseptic and antiseptic procedures during medical practice, removal of unnecessary invasive devices as soon as possible, and compliance with hand hygiene. These procedures were implemented during all study periods (14) . Necessary cultures were obtained from patients in terms of fever, any changes in general condition, and suspicion of infection in the ICU.
Ethical approval
The ethical approval for this study was obtained from the Sakarya University Faculty of Medicine Ethics Committee on 23 December 2014 (No: 71522473/050.01.04/1).
Statistical analysis
Data were evaluated using the computer program Epiinfo (CDC, Atlanta, GA, USA). Student's t-test was used to evaluate the quantitative variables; chi-square and Yates corrected chi-square tests were used to evaluate the qualitative data. P < 0.05 was considered significant.
Results
This study was carried out during three periods: 1053 patients were tracked during SP-1, 1322 patients were tracked during SP-2, and 2085 patients were tracked during SP-3. Patient and microbiological data are summarized in the Table. Among the study periods, SP-2 had the lowest hospital infection rate [11.4% during SP-1, 6% during SP-2, and 7.8% during SP-3 (P < 0.001)]. The density of hospital infections during SP-1 = 19.6; during SP-2 = 7.6, and during SP-3 = 7.1 (P < 0.001).
The consumption amount of antibiotics is shown in Figure 1 . While there was a significant difference in antibiotic consumption between SP-1 and SP-2 (P = 0.01), there was no difference between SP-2 and SP-3 (P > 0.05) (Figure 1 ).
The distribution of antibiotic consumption according to study periods is given in Figure 2 . In the restriction period of G2C, the use of certain antibiotics (piperacillin/ tazobactam and colistin) has increased.
The distribution of pathogens is given in Figure 3 . While a significant difference was found in terms of Acinetobacter, Klebsiella, Pseudomonas, and Candida, there was no difference among the others.
Infection-related mortality was 7.3% during SP-1, while it was 5% (P = 0.02, OR: 1.49) during SP-2, and 3.8% during SP-3 (P < 0.001) (Table) .
Discussion
Resistant infections are one of the leading causes of mortality in the ICU (15, 16) . Many strategies have been tried to deal with this problem (17) . In one of these strategies, antibiotic stewardships have been applied, i.e. limited use of antibiotics, rational use of antibiotics, and use of antibiotics with rotation (18) . The usage of broad spectrum antibiotics has caused collateral damage in the hospital bacterial flora. Limitation of broad spectrum antibiotic usage in a hospital may decrease the percentage of antibiotic-resistant bacteria. We hypothesized that antibiotic restriction during defined periods can change hospital infection pathogens in the ICU as well as physician behaviors. Moreover, antibiotic rotation strategies are needed to reduce antimicrobial resistance. For this reason, we have used this strategy in our hospital for more than 8 years.
In this study, antibiotic restriction and later removal of the restriction have been investigated to determine what kind of behavior it causes in physicians who prescribe antibiotics (19) . The study consisted of three periods. Carbapenem was used freely for 10 months (SP-1). After this period, G2C was restricted for 17 months (SP-2), and then all carbapenem prescription was released again for 27 months (SP-3). According to the basic results of this study, there was a decrease in the frequency of Acinetobacter, Pseudomonas, and Klebsiella spp.-related infections during the restricted period. Moreover, the usage of broad spectrum antibiotics during the restricted period and during the released restriction period decreased as well. After releasing the restriction, consumption of G2C did not increase, without any change in infection-related mortality.
The most striking finding of this study is that reduction in antibiotic consumption with restriction continues to decrease even when the restriction is removed. The use of G2C continued to decline both during the period of restriction and during the release of the restriction. In contrast, both during the restriction period and during the releasing of the restriction period, the use of colistin, piperacillin/tazobactam, and ertapenem increased. The increase in colistin consumption might be related to G2C limitation. Clinicians may choose to prescribe colistin during the G2C period due to antipseudomonal and antiAcinetobacter effect of colistin. Increased use of colistin in the SP-3 may be related to habits gained with colistin use. Interestingly, quinolone consumption decreased without restriction. In ICUs in our center, quinolones are generally used in combination with G2C. We think that physicians who cannot use G2C during the restriction period do not include quinolones in the treatment either. Therefore, the restriction of carbapenems might reduce consumption of combined drugs such as quinolones or aminoglycosides as well.
Although all antibiotic restrictions were removed in SP-3, it was observed that the doctors who have the ability to prescribe any antibiotic freely continue to restrict themselves. During this period, while IDCMS were able to prescribe G2C, they still did not do so. We think that this can depend on the belief that treatments that do not contain G2C are as successful as those that do. Moreover, during SP-2, not only G2C consumption but also total antibiotic consumption decreased. We think that these findings are important for the rational use of antibiotics.
With the spread of this application, restriction of some antibiotics might be implemented in antibiotic stewardship programs (16) . We also examined total mortality, frequency of Acinetobacter infections, and mortality from infections other than Acinetobacter during restricted and unrestricted periods. We found that mortality due to Acinetobacter or non-Acinetobacter infections did not increase.
An important result of our study is that ICU pseudomonas epidemiology is clearly influenced by antibiotic consumption. Our results suggest that if wide spectrum antibiotic consumption can be limited, pseudomonas infection rate will decrease. On the other hand, we observed that Candida spp.-related infections tended to increase in spite of decrease in antibiotic consumption. We do not have a significant hypothesis about this finding. It needs a more comprehensive investigation.
The most important limitation of our work is that the study design was performed retrospectively and in a single center. If this work could be done as a multicenter study, local differences such as training frequency, infection control practices, and acceptance of new knowledge by some physicians could be excluded.
Finally, hospitals should monitor antibiotic use policies during certain periods and develop restricted formulas based on their own observations. As a result, we think that well-planned antibiotic restraint practices can play an important role in encouraging rational antibiotic use. 
